Diagnosing type 2 diabetes mellitus: In primary care, fasting plasma glucose and glycosylated hemoglobin do the job;Diagnosticando la diabetes mellitus tipo 2: En atención primaria, con la glucemia basal y la hemoglobina glucosilada es suficiente

Atencion Primaria

Volumn 34, Issue 5, 2004, Pages 222-228

  Jimeno Mollet, J ^a   Molist Brunet, N ^a   Franch Nadal, J ^a,b   Morato Griera J ^a   Otzet Gramunt, I ^a   Pons Barro, P ^a  

^a ABS Raval Sud ^*  (Spain)

^b ABS Raval Sud   (Spain)

Author keywords

Diabetes mellitus; Diagnosis; Fasting plasma glucose; Glycosylated hemoglobin; Oral glucose overload

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; DIAGNOSTIC TEST; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIMARY MEDICAL CARE; RECEIVER OPERATING CHARACTERISTIC;

AGED; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; REFERENCE VALUES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION;

EID: 7644220749     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1157/13066409     Document Type: Article

References (29)

1. Zimmet P. Type 2 (non-insulin-dependent) diabetes: an epidemiological overview. Diabetologia 1982;22:399-411.
2. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
3. World Health Organisation Study Group. Diabetes mellitus. WHO Tech Rep Ser 1985;727:1-104.
4. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report. Diabetes Care 1997;20:1183-97.
5. McCance DR, Hanson RL, Charles MA, Jacobsson LTH, Pettitt DJ, Bennett PH, et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 1994;308:1323-8.
6. Engelgau MM, Thompson TJ, Herman WH, et al. Comparison of fasting and 2-hour glucose and A1C levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care 1997;20:785-91.
7. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneve: World Health Organization, 1999.
8. Diabetes Control and Complication Trial Research Group. The effect of intensive treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
9. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
10. Park S, Barrett-Connor E, Wingard DL, Shan J, Edelstein S. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care 1996;19:450-6.
11. Santiago JV, Davis JE, Fiaher F. Hemoglobin A1c levels in a diabetes detection program. J Clin Endocrinol Metab 1978;47:578-80.
12. Cederholm J, Ronquist G, Wibell L. Comparison of glycosylated hemoglobin with oral glucose tolerance test. Diabet Metab 1984;10:224-9.
13. Gibb I, Parnham AJ, Lord C, Steffes MW, Bucksa J, Marshall S. Standardization of glycated haemoglobin assays throughout the Nortern region of England: a pilot study. Diabetic Med 1997;14:584-8.
14. Gillery P, Dumont G, Vassault A. Evaluation of GHb assays in France by national quality control surveys. Diabetes Care 1998;21:265-70.
15. Kilpatrick ES, Maylor PW, Keevil BG. Biological variation of glycated hemoglobin. Diabetes Care 1998;21:261-4.
16. Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus. An analysis using glycosylated hemoglobin levels. JAMA 1996;276:1246-52.
17. Davidson MB, Schriger DL, Peters AL, Lorber B. Relationship between fasting plasma glucose and gycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 1999;281:1203-10.
18. Goday A, Serrano-Ríos M. Epidemiología de la diabetes mellitus en España. Revisión crítica y nuevas perspectivas. Med Clin (Barc) 1994;102:306-15.
19. Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC. Association of A1C with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 1992;41:202-8.
20. Klein R, Klein BEK, Moss SE. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 1996;124:90-6.
21. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258-68.
22. Mooy JM, Grootenhuis PA, De Vries H, Kostense PJ, Popp-Snijders C, Bouter LM, et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance test in a general Caucasian population: the Hoorn Study. Diabetologia 1996;39:298-305.
23. Knowler WC. Screening for NIDDM: opportunities for detection, treatment, and prevention. Diabetes Care 1994;17:445-50.
24. Finch CF, Zimmet PZ, Alberti KG. Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? Diabetic Med 1990;7:603-10.
25. Nathan DM. The pathophysiology of diabetic complications: how much does the glucose hypothesis explain? Ann Intern Med 1996;124:86-9.
26. Rohlfing C, Little RR, Wiedmeyer HM, England JD, Madsen R, Harris MI, et al. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the US population. Diabetes Care 2000;23:187-91.
27. Tsuji I, Nakamoto K, Hasegawa T, Hisashige A, Inawashiro H, Fukao A, et al. HbA1c was as accurate as fasting plasma glucose for diabetes screening. Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening. Diabetes Care 1991;14:1075-7.
28. Takahashi Y, Noda M, Tsugane S, Kuzuya T, Ito C, Kadowaki T. Prevalence of diabetes estimated by plasma glucose criteria combined with standardized measurement of HbA1c among health checkup participants on Miyako Island, Japan. Diabetes Care 2000;23:1092-6.
29. Ko TC, Li JKY, Chan JCN, So WI, Yeung VTF, Wai HPS, et al. Combined use of a fasting plasma glucose concentration and A1C or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diabetes Care 1998;21:1221-5.